King buys rights to sell abuse-resistant OxyContin

11/10/2005 | NYTimes.com

King Pharmaceuticals and Pain Therapeutics say they have reached a deal to give King the rights to a new version of the painkiller OxyContin. King obtained the rights to the abuse-resistant version of the drug for a reported $150 million up front with an additional $150 million possibly due depending on the speed with which Remoxy moves through the regulatory process.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC